Articles written by: Leroy Gutman

Comparison of SELLAS Life Sciences Group Inc. (SLS) and Avid Bioservices Inc. (NASDAQ:CDMO)

Both SELLAS Life Sciences Group Inc. (NASDAQ:SLS) and Avid Bioservices Inc. (NASDAQ:CDMO) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SELLAS […]

Comparison of Obalon Therapeutics Inc. (OBLN) and SI-BONE Inc. (NASDAQ:SIBN)

As Medical Appliances & Equipment businesses, Obalon Therapeutics Inc. (NASDAQ:OBLN) and SI-BONE Inc. (NASDAQ:SIBN), are affected by contrast. This especially applies to their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Obalon Therapeutics Inc. […]

Comparing of Eaton Vance High Income 2021 Target Term Trust (EHT) and Federated Investors Inc. (NYSE:FII)

Both Eaton Vance High Income 2021 Target Term Trust (NYSE:EHT) and Federated Investors Inc. (NYSE:FII) are each other’s competitor in the Asset Management industry. Thus the contrast of their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Reviewing Matinas BioPharma Holdings Inc. (MTNB)’s and Apellis Pharmaceuticals Inc. (NASDAQ:APLS)’s results

As Biotechnology companies, Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) and Apellis Pharmaceuticals Inc. (NASDAQ:APLS) are our subject to compare. And more specifically their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Matinas BioPharma Holdings Inc. […]

Contrasting of Kodiak Sciences Inc. (KOD) and Affimed N.V. (NASDAQ:AFMD)

We are contrasting Kodiak Sciences Inc. (NASDAQ:KOD) and Affimed N.V. (NASDAQ:AFMD) on their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kodiak Sciences Inc. N/A 0.00 […]

BiondVax Pharmaceuticals Ltd. (BVXV)’s Financial Results Comparing With Soligenix Inc. (NASDAQ:SNGX)

This is a contrast between BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) and Soligenix Inc. (NASDAQ:SNGX) based on their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing Benitec Biopharma Limited (BNTC)’s and Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR)’s results

We are comparing Benitec Biopharma Limited (NASDAQ:BNTC) and Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) on their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Benitec Biopharma Limited N/A […]

National Presto Industries Inc. (NPK)’s Financial Results Comparing With Elbit Systems Ltd. (NASDAQ:ESLT)

As Aerospace/Defense Products & Services businesses, National Presto Industries Inc. (NYSE:NPK) and Elbit Systems Ltd. (NASDAQ:ESLT), are affected by contrast. This especially applies to their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio National […]

Contrasting of Intercept Pharmaceuticals Inc. (ICPT) and Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) and Intra-Cellular Therapies Inc. (NASDAQ:ITCI), both competing one another are Biotechnology companies. We will contrast their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Intercept Pharmaceuticals Inc. 179.80M 18.06 309.24M […]

Polymath Network (POLY*) hits new $0.0380784768 price after 37.66% step up for a day

Polymath Network (POLY*) had a good 24 hours as the cryptocurrency jumped $0.0380784768 or 37.66% trading at $0.139194432. According to International Cryptocoin Analysts, Polymath Network (POLY*) eyes $0.1531138752 target on the road to $0.26240562570968. POLY* last traded at Binance exchange. It had high of $0.1507539696 and low of $0.100595976 for […]